Harnessing helminth-driven immunoregulation in the search for novel therapeutic modalities
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Parasitic helminths have coevolved with humans over millennia, intricately refining and developing an array of mechanisms to suppress or skew the host's immune system, thereby promoting their long-term survival. Some helminths, such as hookworms, cause little to no overt pathology when present in modest numbers and may even confer benefits to their human host. To exploit this evolutionary phenomenon, clinical trials of human helminth infection have been established and assessed for safety and efficacy for a range of immune dysfunction diseases and have yielded mixed outcomes. Studies of live helminth therapy in mice and larger animals have convincingly shown that helminths and their excretory/secretory products possess anti-inflammatory drug-like properties and represent an untapped pharmacopeia. These anti-inflammatory moieties include extracellular vesicles, proteins, glycans, post-translational modifications, and various metabolites. Although the concept of helminth-inspired therapies holds promise, it also presents a challenge to the drug development community, which is generally unfamiliar with foreign biologics that do not behave like antibodies. Identification and characterization of helminth molecules and vesicles and the molecular pathways they target in the host present a unique opportunity to develop tailored drugs inspired by nature that are efficacious, safe, and have minimal immunogenicity. Even so, much work remains to mine and assess this out-of-the-box therapeutic modality. Industry-based organizations need to consider long-haul investments aimed at unraveling and exploiting unique and differentiated mechanisms of action as opposed to toe-dipping entries with an eye on rapid and profitable turnarounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hay fever, hygiene, and household size.
Strachan, D. P. (1989) · BMJ · doi:10.1136/bmj.299.6710.1259 · Cited by 5,054
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit
von Moltke, J., Ji, M., Liang, H.-E., & Locksley, R. M. (2016) · Nature · doi:10.1038/nature16161 · Cited by 1,230
Diversity and dialogue in immunity to helminths
Allen, J. E., & Maizels, R. M. (2011) · Nature reviews. Immunology · doi:10.1038/nri2992 · Cited by 831 · cited 2×
“Recombinant AIPs suppressed expression of DC activation and costimulation markers [52, 70] and drove the subsequent expansion and mucosal homing of Tregs, which protected against inducible asthma [51].”
BackgroundBuck, A. H., Coakley, G., Simbari, F., McSorley, H. J., Quintana, J. F., Le Bihan, T., Kumar, S., Abreu-Goodger, C., Lear, M., Harcus, Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms6488 · Cited by 770
Trichuris suis therapy in Crohn’s disease
Summers, R. W., Elliott, D. E., Urban, J. F., Thompson, R., & Weinstock, J. V. (2005) · Gut · doi:10.1136/gut.2004.041749 · Cited by 762
Grainger, J. R., Smith, K. A., Hewitson, J. P., McSorley, H. J., Harcus, Y., Filbey, K. J., Finney, C. A. M., Greenwood, E. J. D., Knox, D. P., Wilson, M. S., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101074 · Cited by 469
The intestinal microbiota contributes to the ability of helminths to modulate allergic inflammation
Zaiss, M. M., Rapin, A., Lebon, L., Dubey, L. K., Mosconi, I., Sarter, K., Piersigilli, A., Menin, L., Walker, A. W., Rougemont, J., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.012 · Cited by 437
Self-citationModulation of Host Immunity by Helminths: The Expanding Repertoire of Parasite Effector Molecules
Maizels, R. M., Smits, H. H., & McSorley, H. J. (2018) · Immunity · doi:10.1016/j.immuni.2018.10.016 · Cited by 435
Targeting innate immune mediators in type 1 and type 2 diabetes
Donath, M. Y., Dinarello, C. A., & Mandrup-Poulsen, T. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0213-9 · Cited by 416 · cited 1×
“However, methods for the production of cGMP human hookworms were recently described [34] and are essential advances if helminth therapy is to receive widespread acceptance by the medical fraternity [35].”
MethodJohnston, C. J. C., Smyth, D. J., Kodali, R. B., White, M. P. J., Harcus, Y., Filbey, K. J., Hewitson, J. P., Hinck, C. S., Ivens, A., Kemter, A. M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01886-6 · Cited by 197
Eichenberger, R. M., Ryan, S., Jones, L., Buitrago, G., Polster, R., Montes de Oca, M., Zuvelek, J., Giacomin, P. R., Dent, L. A., Engwerda, C. R., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00850 · Cited by 197
Self-citationHpARI protein secreted by a helminth parasite suppresses interleukin-33
Osbourn, M., Soares, D. C., Vacca, F., Cohen, E. S., Scott, I. C., Gregory, W. F., Smyth, D. J., Toivakka, M., Kemter, A. M., le Bihan, T., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.09.015 · Cited by 178
Dietary Fiber-Induced Microbial Short Chain Fatty Acids Suppress ILC2-Dependent Airway Inflammation
Lewis, G., Wang, B., Shafiei Jahani, P., Hurrell, B. P., Banie, H., Aleman Muench, G. R., Maazi, H., Helou, D. G., Howard, E., Galle-Treger, L., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02051 · Cited by 163
Hookworm recombinant protein promotes regulatory T cell responses that suppress experimental asthma
Navarro, S., Pickering, D. A., Ferreira, I. B., Jones, L., Ryan, S., Troy, S., Leech, A., Hotez, P. J., Zhan, B., Laha, T., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf8807 · Cited by 139 · cited 3×
“Recombinant AIPs suppressed expression of DC activation and costimulation markers [52, 70] and drove the subsequent expansion and mucosal homing of Tregs, which protected against inducible asthma [51].”
BackgroundSelf-citationRegulatory B-cell induction by helminths: implications for allergic disease
Hussaarts, L., van der Vlugt, L. E. P. M., Yazdanbakhsh, M., & Smits, H. H. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.05.012 · Cited by 131
Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics
Sil, S., Dagur, R. S., Liao, K., Peeples, E. S., Hu, G., Periyasamy, P., & Buch, S. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09873-y · Cited by 109
Haeberlein, S., Obieglo, K., Ozir-Fazalalikhan, A., Chayé, M. A. M., Veninga, H., van der Vlugt, L. E. P. M., Voskamp, A., Boon, L., den Haan, J. M. M., Westerhof, L. B., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006539 · Cited by 96
Smout, M. J., Sotillo, J., Laha, T., Papatpremsiri, A., Rinaldi, G., Pimenta, R. N., Chan, L. Y., Johnson, M. S., Turnbull, L., Whitchurch, C. B., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005209 · Cited by 94 · cited 1×
“The liver fluke, Opisthorchis viverrini, secretes a granulin (GRN)-like growth factor, Ov-GRN-1, which promotes wound healing and angiogenesis [87].”
BackgroundSelf-citationPineda, M. A., Lumb, F., Harnett, M. M., & Harnett, W. (2014) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2014.03.003 · Cited by 88 · cited 1×
“This glycoprotein that has therapeutic effects in a range of mouse models of inflammatory disorders such as arthritis [91], asthma [92], and even systemic lupus erythematosus [93].”
BackgroundWang, S., Xie, Y., Yang, X., Wang, X., Yan, K., Zhong, Z., Wang, X., Xu, Y., Zhang, Y., Liu, F., et al. (2016) · Parasites & Vectors · doi:10.1186/s13071-015-1288-1 · Cited by 75
A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn’s disease
Schölmerich, J., Fellermann, K., Seibold, F. W., Rogler, G., Langhorst, J., Howaldt, S., Novacek, G., Petersen, A. M., Bachmann, O., Matthes, H., et al. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw184 · Cited by 66
Laan, L. C., Williams, A. R., Stavenhagen, K., Giera, M., Kooij, G., Vlasakov, I., Kalay, H., Kringel, H., Nejsum, P., Thamsborg, S. M., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201600841r · Cited by 63
Daniłowicz-Luebert, E., Steinfelder, S., Kühl, A. A., Drozdenko, G., Lucius, R., Worm, M., Hamelmann, E., & Hartmann, S. (2013) · International Journal for Parasitology · doi:10.1016/j.ijpara.2012.10.014 · Cited by 52
Tribolet, L., Cantacessi, C., Pickering, D. A., Navarro, S., Doolan, D. L., Trieu, A., Fei, H., Chao, Y., Hofmann, A., Gasser, R. B., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu451 · Cited by 48 · cited 1×
“Na-ASP-2 was shown to bind to CD79A on human B cells whereupon it affected the expression of genes involved in leukocyte transendothelial migration [82].”
BackgroundSelf-citationA recombinant cystatin from Ascaris lumbricoides attenuates inflammation of DSS‐induced colitis
Coronado, S., Barrios, L., Zakzuk, J., Regino, R., Ahumada, V., Franco, L., Ocampo, Y., & Caraballo, L. (2017) · Parasite Immunology · doi:10.1111/pim.12425 · Cited by 46
Wangchuk, P., Shepherd, C., Constantinoiu, C., Ryan, R. Y. M., Kouremenos, K. A., Becker, L., Jones, L., Buitrago, G., Giacomin, P., Wilson, D., et al. (2019) · Infection and Immunity · doi:10.1128/iai.00851-18 · Cited by 42
Self-citationSuckling, C. J., Mukherjee, S., Khalaf, A. I., Narayan, A., Scott, F. J., Khare, S., Dhakshinamoorthy, S., Harnett, M. M., & Harnett, W. (2018) · Acta Tropica · doi:10.1016/j.actatropica.2018.05.015 · Cited by 12 · cited 1×
“Small drug-like analogs of PC for the treatment of arthritis and chronic lung fibrosis have overcome immunogenicity concerns with the sizeable ES-62 protein [97, 98].”
Background
Cited by
Fleming, J., Hernandez, G., Hartman, L., Maksimovic, J., Nace, S., Lawler, B., Risa, T., Cook, T., Agni, R., Reichelderfer, M., et al. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458517736377 · Cited by 74
Helminth Therapy for Immune-Mediated Inflammatory Diseases: Current and Future Perspectives
Shi, W., Xu, N., Wang, X., Vallée, I., Liu, M., & Liu, X. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s348079 · Cited by 46
Myeloid-Derived Suppressor Cells: The Expanding World of Helminth Modulation of the Immune System
Stevenson, M. M., Valanparambil, R. M., & Tam, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.874308 · Cited by 23
van der Kaaij, A., van Noort, K., Nibbering, P., Wilbers, R. H. P., & Schots, A. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.882835 · Cited by 13
Packi, K., Świerczewski, D., Klimczak, S., Ochab, D., Gałęziewska, J., Gromek, P., Kruczkowska, W., Płuciennik, E., Kałuzińska-Kołat, Ż., & Kołat, D. (2026) · Antonie van Leeuwenhoek · doi:10.1007/s10482-026-02425-4
Metadata
- Authors
- Ryan, S. M., Eichenberger, R. M., Ruscher, R., Giacomin, P. R., & Loukas, A.
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-05-14
- Volume
- 16
- Issue
- 5
- Pages
- e1008508
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W3024793066
- Cited by
- 123
- References
- 28
- FWCI
- 13.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.